Cell-Permeable HSP70 Protects Neurons and Astrocytes Against Cell Death in the Rotenone-Induced and Familial Models of Parkinson’s Disease
Molecular Neurobiology · 2024
DOI: 10.1007/s12035-024-04077-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Neurobiology, 2024. Verfasst von Andrey Y Vinokurov und 7 weiteren Autor:innen. Beteiligte Einrichtung: Orel State University, Orel, Russia. Hauptthemen laut MEDLINE: Astrocytes, Rotenone, Neurons, HSP70 Heat-Shock Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Heat shock protein 70 (HSP70) is activated under stress response. Its involvement in cell protection, including energy metabolism and quality control makes it a promising pharmacological target. A strategy to increase HSP70 levels inside the cells is the application of recombinant HSP70. However, cell permeability and functionality of these exogenously applied proteins inside the cells is still disputable. Here, using fluorescence- labeled HSP70, we have studied permeability and distribution of HSP70 inside primary neurons and astrocytes, and how exogenous HSP70 changes mitochondrial metabolism and mitophagy. We have found that exogenous recombinant HSP70 can penetrate the neurons and astrocytes and distributes in mitochondria, lysosomes and in lesser degree in the endoplasmic reticulum. HSP70 increases mitochondrial membrane potential in control neurons and astrocytes, and in fibroblasts of patients with familial Parkinson´s disease (PD) with PINK1 and LRRK2 mutations. Increased mitochondrial membrane potential was associated with higher mitochondrial ROS production and activation of mitophagy. Importantly, preincubation of the cells with HSP70 protected neurons and astrocytes against cell death in a toxic model of PD induced by rotenone, and in the PINK1 and LRRK2 PD human fibroblasts. Thus, exogenous recombinant HSP70 is cell permeable, and acts as endogenous HSP70 protecting cells in the case of toxic model and familial forms of Parkinson’s Disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Orel State University, Orel, Russia.
- Institute of Cell Biophysics of the Russian Academy of Sciences, 142290, Pushchino, Russia.
- Laboratory of Molecular Neurobiology, Academy of Biology and Biotechnology, Southern Federal University, 344090, Rostov-On-Don, Russia.
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991, Moscow, Russia.
- Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
- Department of Biochemistry and Molecular Biology, School of Medicine, Complutense University of Madrid, Madrid, Spain.
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Vinokurov, A. Y., Palalov, A. A., Kritskaya, K. A., Demyanenko, S. V., Garbuz, D. G., Evgen'ev, M. B., Esteras, N., & Abramov, A. Y. (2024). Cell-Permeable HSP70 Protects Neurons and Astrocytes Against Cell Death in the Rotenone-Induced and Familial Models of Parkinson’s Disease. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04077-9
Vancouver
Vinokurov AY, Palalov AA, Kritskaya KA, Demyanenko SV, Garbuz DG, Evgen'ev MB, et al. Cell-Permeable HSP70 Protects Neurons and Astrocytes Against Cell Death in the Rotenone-Induced and Familial Models of Parkinson’s Disease. Molecular Neurobiology. 2024. doi:10.1007/s12035-024-04077-9
BibTeX
@article{Vinokurov2024,
author = {Vinokurov, Andrey Y and Palalov, Alexander A and Kritskaya, Kristina A and Demyanenko, Svetlana V and Garbuz, David G and Evgen'ev, Michael B and Esteras, Noemi and Abramov, Andrey Y},
title = {Cell-Permeable HSP70 Protects Neurons and Astrocytes Against Cell Death in the Rotenone-Induced and Familial Models of Parkinson’s Disease},
journal = {Molecular Neurobiology},
year = {2024},
doi = {10.1007/s12035-024-04077-9}
}
EUVIMED